High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Expense ratios, sector weights, and portfolio size set these two small-cap value ETFs apart for investors comparing risk and diversification.
Nvidia faces a stronger challenge from the law of large numbers.
Quanex’s 16% return over the past six months has outpaced the S&P 500 by 9.8%, and its stock price has climbed to $17.78 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Indivior, which is adding big gains this week, deserves attention as it meets practically every factor in the stock picking methodology of Investor's Business Daily. Thus it serves as Thursday's IBD 50 Stocks To Watch pick. Also this week, Indivior's relative strength line has bolted to new high ground.
As a general rule, I expect covered call ETFs to lag the broader market over time. The math is not particularly favorable. You cap your upside, retain most of the downside, pay higher management fees, and often generate taxable distributions along the way. Even after reinvesting those distributions, many covered call ETFs struggle to keep ... It’s Pretty Insane How Much TPAY’s 10% Yield Beats Most Covered Call ETFs
Cathie Wood, chief of Ark Investment Management, likes to double down on her favorite tech stocks, especially when the prices are falling. That’s what she just did, buying a megacap tech stock amid a broader market sell-off. In 2025, the flagship Ark Innovation ETF gained 35.49%, far outpacing the ...
Since June 2021, the S&P 500 has delivered a total return of 72%. But one standout stock has more than doubled the market - over the past five years, Permian Resources has surged 155% to $18.71 per share. Its momentum hasn’t stopped as it’s also gained 36.1% in the last six months, beating the S&P by 29.8%.
GM is still an automotive company, and the industry is facing plenty of headwinds.
Over the past six months, Deere has been a great trade, beating the S&P 500 by 22.1%. Its stock price has climbed to $602, representing a healthy 28.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
The stock market is leaving Big Tech stocks in the dust. The Dow surged 733 points, or 1.4%, while the S&P 500 gained 0.3%. The Nasdaq, which was up nearly 1% at the open, was down 0.6%. More than four-in-five S&P 500 stocks were set to close higher, but the Roundhill Magnificent Seven ETF dropped 2%.
It is happening again. The Nasdaq, after opening higher and riding a rebound in tech stocks, turned sharply lower. It's exactly what happened on Wednesday. This time, it is down 0.6%. The S&P 500 rose 0.
The struggling fast-food chain is seeing more action than the red-hot memory-chip maker, which just posted stellar earnings.
AI was supposed to be a tide that lifted all ships within the sector. Microsoft (NASDAQ: MSFT) is the leading exception. So far this year, the stock is down 24%. The market is 7% higher, and the market’s long-term trade is just bad or worse. Over the last five years, the stock has risen 38% ... Microsoft’s Stock Is Crippled
This oil supermajor's stock has outperformed the market in 2026. What's the best approach to take now?
Even if they go mostly unnoticed, industrial businesses are the backbone of our country. But their prominence also brings high exposure to the ups and downs of economic cycles. Luckily, the tide is turning in their favor as the industry’s 18.7% return over the past six months has topped the S&P 500 by 12.5 percentage points.
The Federal Reserve's primary inflation gauge, the core PCE price index, showed the 12-month inflation rate hitting its highest level since October 2023, as Wall Street expected. S&P 500 futures are solidly higher early Thursday after a three-session losing streak sparked in part by the prospect for tighter monetary policy under new Fed Chairman Kevin Warsh. Rate-hike expectations have sent the U.S. dollar surging to its highest level in more than a year, even as prospects for rate hikes by other global central banks have faded with tumbling oil prices.
It's a good buy, but not if you're trying to duplicate recent results.
Bond yields dropped and stocks kept rising after the Federal Reserve’s benchmark inflation gauge matched expectations. The core personal expenditures price index, which excludes volatile food and energy prices and is watched closely by the central bank, rose at a 0.
The company almost doubles its non-handset sales target, helping to revive faith in the stumbling AI trade.
Stock Market Today: The Dow Jones index rose Thursday ahead of a key inflation gauge. Micron stock rocketed 17% on earnings.
Pre-Market Stock Futures: Futures are trading higher this morning, after all the big funds and portfolio managers may have shown their hands on Wednesday, as the tech and chip stocks sell-off resumed after stocks started higher in the morning but faded in the afternoon. The tech sell-off came before Micron Technology (NASDAQ: MU) posted huge ... Here Are Thursday’s Best Wall Street Analyst Research Calls: Brown-Forman, CoreWeave, Intel, JFrog, Keurig Dr. Pepper, Klarna Group, Qualcomm, Shift 4 P
Both ETFs mirror the S&P 500's performance, but their investor bases and expense ratios set them apart.
"Buy low and sell high" is one of the oft-repeated adages on Wall Street. But it's not working as many S&P 500 investors "buy high and sell higher."
US equity futures were higher pre-bell Thursday as oil prices fell to their lowest since the start o
Financial firms serve as the backbone of the economy, providing essential services from lending and investment management to risk management and payment processing. But worries about economic uncertainty and potential market volatility have kept sentiment in check, and over the past six months, the industry has tumbled by 3.7%. This performance was disappointing since the S&P 500 climbed 6.3%.
Shares of Bio-Techne surged before the opening bell on Thursday after Germany’s Merck KGaA announced it has agreed to purchase the company for $11.3 billion. Bio-Techne stock jumped 21% to $70.95 in premarket trading on Thursday. Merck KGaA plans to acquire Bio-Techne for $73 a share, according to the media release, representing a 24% premium based on the stock’s closing price from Wednesday.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
